Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
05/01/2007 | CA2206748C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetylamino)-3-phenylpropionate |
04/26/2007 | WO2007047331A1 Process for producing n-halogenated hydrantoins |
04/26/2007 | WO2007046075A1 Piperazine derivatives as antimalarial agents |
04/26/2007 | WO2007045551A2 Renin inhibitors nitroderivatives |
04/26/2007 | WO2006072775A3 Ionic liquids with a cation comprising a basic moiety |
04/26/2007 | WO2005115991A8 Anti-cytokine heterocyclic compounds |
04/26/2007 | US20070093492 Pyrrolidine derivatives |
04/26/2007 | US20070092566 Oral sustained-release tablet |
04/26/2007 | US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers |
04/26/2007 | CA2626568A1 Renin inhibitors nitroderivatives |
04/26/2007 | CA2624166A1 Inhibitors of viral replication |
04/26/2007 | CA2623213A1 Piperazine derivatives as antimalarial agents |
04/25/2007 | EP1776347A1 Sulphonamide derivatives, their preparation and their therapeutic application |
04/25/2007 | EP1478652B1 Components for producing amphoteric liposomes |
04/25/2007 | EP1305294B1 Imidazolyl derivatives |
04/25/2007 | EP1292578B1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations |
04/25/2007 | CN1953965A Novel cis-imidazolines |
04/25/2007 | CN1312120C Adamantane derivatives |
04/25/2007 | CN1312106C Preparation method of water soluble curcumin composition salt |
04/25/2007 | CN1312087C Method for producing molecular compound |
04/24/2007 | US7208628 Compositions and methods for the treatment of hepatitis C virus infection |
04/24/2007 | US7208605 Functionalized ionic liquids, and methods of use thereof |
04/24/2007 | US7208527 Potassium channel modulators |
04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
04/24/2007 | CA2281471C Process for preparing eprosartan |
04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
04/19/2007 | WO2007042910A1 Imidazoles and their use as hmg-coa reductase inhibitors |
04/19/2007 | WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases |
04/19/2007 | WO2007042545A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
04/19/2007 | WO2007042543A2 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
04/19/2007 | US20070088170 Novel compounds |
04/19/2007 | US20070088069 Novel imidazoles |
04/19/2007 | CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases |
04/18/2007 | EP1775289A1 Novel imidazolidine derivatives |
04/18/2007 | EP1773848A2 Salts containing alkoxytris (fluoroalkyl) borate anions |
04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
04/18/2007 | EP1773785A2 High stability diionic liquid salts |
04/18/2007 | EP1773763A1 Lysine based compounds |
04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
04/18/2007 | EP1773348A2 Tetrapeptide analogs |
04/18/2007 | EP1773326A2 Mitotic kinesin inhibitors |
04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
04/18/2007 | CN1950970A Material for electrolytic solution, ionic material-containing composition and use thereof |
04/18/2007 | CN1950343A Basic amine compound and use thereof |
04/18/2007 | CN1950342A Novel compounds as opioid receptor modulators |
04/18/2007 | CN1948314A 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method |
04/18/2007 | CN1310905C Antivirally active heterocyclic azahexane derivatives |
04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
04/17/2007 | US7205435 Type B botulism toxin inhibitors |
04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
04/17/2007 | CA2250586C Meta-substituted phenylene sulphonamide derivatives |
04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
04/12/2007 | WO2007041048A2 Synthesis of imidazole-2-thiones via thiohydantoins |
04/12/2007 | WO2007039821A2 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics |
04/12/2007 | WO2007039580A1 Imidazolyl-substituted benzophenone compounds |
04/12/2007 | WO2007039117A2 A process for the preparation of sartan derivatives and intermediates useful in such process |
04/12/2007 | WO2007012670A3 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists |
04/12/2007 | WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases |
04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
04/11/2007 | EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
04/11/2007 | CN1946710A Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
04/11/2007 | CN1946397A Ion channel modulators |
04/11/2007 | CN1944427A Novel macro-molecular compound, its preparing method and use |
04/11/2007 | CN1944414A Diphenyl-imidazole compound and its preparing method |
04/10/2007 | US7202379 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof |
04/10/2007 | US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound |
04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
04/10/2007 | US7202251 Bicyclic anilide spirohydantoin CGRP receptor antagonists |
04/10/2007 | US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules |
04/10/2007 | CA2379270C External preparation for skin diseases containing nitroimidazole |
04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
04/10/2007 | CA2337269C Novel method for preparing synthesis intermediates |
04/10/2007 | CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
04/10/2007 | CA2175420C Process for the preparation of optionally 2-substituted 5-chloroimidazole-4-carbaldehydes |
04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
04/05/2007 | WO2007038659A1 Violet laser excitable dyes and their method of use |
04/05/2007 | WO2007038359A1 Ionic liquids |
04/05/2007 | WO2007038271A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
04/05/2007 | WO2007016012A3 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION |
04/05/2007 | WO2006110037A3 Preparation of 2-substituted 4-chl0r0-5-f0rmylimidaz0les by vilsmeier reaction of the condensation product of glycine and an imido ester with a formamide in the presence of a triflate (trifluormethanξsulphonate) catalyst |
04/05/2007 | US20070078229 Dithiocarbamic esters |
04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
04/05/2007 | US20070078120 Novel piperidine derivative |
04/05/2007 | US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination" |
04/05/2007 | CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound |
04/05/2007 | CA2623245A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
04/04/2007 | EP1770085A1 Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient |
04/04/2007 | EP1768962A1 Method for producing onium salts with a low chloride content |
04/04/2007 | EP1768947A1 Process for the preparation of an (hetero) arylamine |
04/04/2007 | EP1663206B1 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione as non-sedating alpha 2a agonist |
04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
04/04/2007 | CN1942978A Mixture, cation conductor and electrochemical device using those |